Inspira Technologies OXY B.H.N. (IINN) Competitors $1.10 -0.02 (-1.79%) Closing price 10/17/2025 04:00 PM EasternExtended Trading$1.13 +0.03 (+2.73%) As of 10/17/2025 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsFDA EventsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock IINN vs. CTSO, ICCM, NEPH, BDMD, SURG, TMDIF, PYPD, SRTS, APT, and NMTCShould you be buying Inspira Technologies OXY B.H.N. stock or one of its competitors? The main competitors of Inspira Technologies OXY B.H.N. include Cytosorbents (CTSO), IceCure Medical (ICCM), Nephros (NEPH), Baird Medical Investment (BDMD), SurgePays (SURG), Titan Medical (TMDIF), PolyPid (PYPD), Sensus Healthcare (SRTS), Alpha Pro Tech (APT), and NeuroOne Medical Technologies (NMTC). These companies are all part of the "medical equipment" industry. Inspira Technologies OXY B.H.N. vs. Its Competitors Cytosorbents IceCure Medical Nephros Baird Medical Investment SurgePays Titan Medical PolyPid Sensus Healthcare Alpha Pro Tech NeuroOne Medical Technologies Cytosorbents (NASDAQ:CTSO) and Inspira Technologies OXY B.H.N. (NASDAQ:IINN) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their dividends, analyst recommendations, profitability, earnings, risk, media sentiment, institutional ownership and valuation. Do analysts rate CTSO or IINN? Cytosorbents currently has a consensus target price of $5.50, indicating a potential upside of 521.12%. Inspira Technologies OXY B.H.N. has a consensus target price of $2.00, indicating a potential upside of 81.82%. Given Cytosorbents' higher possible upside, equities research analysts plainly believe Cytosorbents is more favorable than Inspira Technologies OXY B.H.N..Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cytosorbents 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00Inspira Technologies OXY B.H.N. 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Does the media prefer CTSO or IINN? In the previous week, Cytosorbents and Cytosorbents both had 2 articles in the media. Inspira Technologies OXY B.H.N.'s average media sentiment score of 0.50 beat Cytosorbents' score of 0.30 indicating that Inspira Technologies OXY B.H.N. is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Cytosorbents 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Inspira Technologies OXY B.H.N. 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Is CTSO or IINN more profitable? Inspira Technologies OXY B.H.N. has a net margin of 0.00% compared to Cytosorbents' net margin of -25.58%. Inspira Technologies OXY B.H.N.'s return on equity of 0.00% beat Cytosorbents' return on equity.Company Net Margins Return on Equity Return on Assets Cytosorbents-25.58% -111.97% -29.00% Inspira Technologies OXY B.H.N. N/A N/A N/A Which has more risk & volatility, CTSO or IINN? Cytosorbents has a beta of 1.28, suggesting that its stock price is 28% more volatile than the S&P 500. Comparatively, Inspira Technologies OXY B.H.N. has a beta of 2.29, suggesting that its stock price is 129% more volatile than the S&P 500. Which has stronger earnings and valuation, CTSO or IINN? Inspira Technologies OXY B.H.N. has lower revenue, but higher earnings than Cytosorbents. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCytosorbents$35.60M1.56-$20.72M-$0.17-5.21Inspira Technologies OXY B.H.N.N/AN/A-$11.05MN/AN/A Do institutionals & insiders believe in CTSO or IINN? 32.9% of Cytosorbents shares are held by institutional investors. Comparatively, 12.7% of Inspira Technologies OXY B.H.N. shares are held by institutional investors. 6.6% of Cytosorbents shares are held by company insiders. Comparatively, 29.4% of Inspira Technologies OXY B.H.N. shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. SummaryInspira Technologies OXY B.H.N. beats Cytosorbents on 7 of the 10 factors compared between the two stocks. Get Inspira Technologies OXY B.H.N. News Delivered to You Automatically Sign up to receive the latest news and ratings for IINN and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding IINN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart IINN vs. The Competition Export to ExcelMetricInspira Technologies OXY B.H.N.MED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$13.88M$7.09B$6.14B$10.56BDividend YieldN/A1.16%5.72%4.83%P/E RatioN/A27.9085.7027.05Price / SalesN/A27.79612.92132.35Price / CashN/A22.3225.8230.35Price / Book3.245.1512.226.58Net Income-$11.05M$179.79M$3.33B$276.84M7 Day Performance-2.65%0.20%1.17%1.93%1 Month Performance-11.29%1.97%6.85%2.19%1 Year Performance-21.43%1.75%58.93%34.62% Inspira Technologies OXY B.H.N. Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)IINNInspira Technologies OXY B.H.N.2.4434 of 5 stars$1.10-1.8%$2.00+81.8%-21.4%$13.88MN/A0.0020News CoverageAnalyst DowngradeShort Interest ↓CTSOCytosorbents1.6978 of 5 stars$0.92-0.9%$5.50+496.7%-18.8%$58.37M$35.60M-5.42220Analyst ForecastICCMIceCure Medical2.1983 of 5 stars$0.84+0.1%$2.64+212.0%+52.4%$57.97M$2.79M-5.2860NEPHNephros2.9341 of 5 stars$5.38+0.7%$5.50+2.2%+242.0%$56.61M$14.16M44.8330News CoverageAnalyst UpgradeShort Interest ↓BDMDBaird Medical InvestmentN/A$1.59+1.3%N/A-49.7%$56.10M$37.04M0.00N/AShort Interest ↑High Trading VolumeSURGSurgePays2.0858 of 5 stars$2.79+3.3%$9.50+240.5%+46.0%$55.17M$60.88M-1.1240News CoverageTMDIFTitan MedicalN/A$0.48+10.8%N/A+1,256.6%$54.74M$17.63M-0.3850News CoveragePYPDPolyPid3.4266 of 5 stars$3.34flat$12.40+271.3%-8.7%$53.10MN/A-0.8780Positive NewsShort Interest ↓SRTSSensus Healthcare2.2138 of 5 stars$3.22+0.3%$8.00+148.4%-51.9%$52.77M$41.81M-53.6740APTAlpha Pro TechN/A$4.78+1.7%N/A-22.0%$50.06M$58.56M12.92120Positive NewsNMTCNeuroOne Medical Technologies1.8851 of 5 stars$0.91+0.8%$2.23+145.3%-9.3%$45M$3.45M-6.0520Short Interest ↑ Related Companies and Tools Related Companies CTSO Alternatives ICCM Alternatives NEPH Alternatives BDMD Alternatives SURG Alternatives TMDIF Alternatives PYPD Alternatives SRTS Alternatives APT Alternatives NMTC Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:IINN) was last updated on 10/19/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredFront-Run Buffett's Shocking Gold MoveA Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredTrump’s new nightmare beginsPorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredBuy UBER immediatelyBULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredMove $1,000 into this stock before Nov 6The End of Tesla? "Hold onto your Tesla stock." That's the message insiders at Tesla have been giving staff...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Inspira Technologies OXY B.H.N. Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Inspira Technologies OXY B.H.N. With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
